Global Hepatitis C Drug Market Is Set for Rapid Growth, to Reach Around USD 27.63 Billion in 2021
Global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% by 2021
Global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% by 2021
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Hepatitis</strong> C <strong>Drug</strong> <strong>Market</strong><br />
o<br />
o<br />
o<br />
o<br />
• 7.3.3. Product portfolio<br />
• 7.3.4. Bus<strong>in</strong>ess strategy<br />
• 7.3.5. Recent developments<br />
7.4. Basel Glaxosmith<br />
• 7.4.1. Overview<br />
• 7.4.2. F<strong>in</strong>ancials<br />
• 7.4.3. Product portfolio<br />
• 7.4.4. Bus<strong>in</strong>ess strategy<br />
• 7.4.5. Recent developments<br />
7.5. Gilead Sciences<br />
• 7.5.1. Overview<br />
• 7.5.2. F<strong>in</strong>ancials<br />
• 7.5.3. Product portfolio<br />
• 7.5.4. Bus<strong>in</strong>ess strategy<br />
• 7.5.5. Recent developments<br />
7.6. Abbvie<br />
• 7.6.1. Overview<br />
• 7.6.2. F<strong>in</strong>ancials<br />
• 7.6.3. Product portfolio<br />
• 7.6.4. Bus<strong>in</strong>ess strategy<br />
• 7.6.5. Recent developments<br />
7.7. Bris<strong>to</strong>l- Myers Squibb.d<br />
• 7.7.1. Overview<br />
• 7.7.2. F<strong>in</strong>ancials<br />
sales@marketresearchs<strong>to</strong>re.com
Change language